Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months
The efficacy of anti-obesity drugs usually does not consider the high degree of interindividual variability in responses to the drug which could affect the decision to withdraw the drug early due to ineffectiveness or to continue therapy according to specific expectations of success. The aim of this...
Main Authors: | Héctor Isaac Rocha-González, Lidia Elizabeth De la Cruz-Álvarez, Ashuin Kammar-García, Samuel Canizales-Quinteros, Juan Carlos Huerta-Cruz, Lina Marcela Barranco-Garduño, Juan Gerardo Reyes-García |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/12/1354 |
Similar Items
-
Combined First Month Body Weight Loss and Development of Tolerance as Predictors of 6-Month Efficacy of Mazindol in Mild and Moderate Obese Subjects
by: Juan Carlos Huerta-Cruz, et al.
Published: (2022-06-01) -
Phentermine-Associated Atrial Fibrillation: Case Report and Literature Review
by: Nouraldeen Manasrah, et al.
Published: (2022-03-01) -
Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial
by: Kwon YJ, et al.
Published: (2021-03-01) -
A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity
by: Kim A, et al.
Published: (2023-08-01) -
Potential drug-drug interactions with phentermine among long-term phentermine consumers: A retrospective analysis
by: A Fourie, et al.
Published: (2023-08-01)